Pharmafile Logo
Pharmafocus logo
Advanced Search

Norgine quits ABPI and denounces big pharma bias

pharmafile | October 6, 2008 | News story | Sales and Marketing |  ABPI, Norgine 

Related Content

Norgine enters exclusive licensing agreement with Vir Biotechnology

Norgine has announced its exclusive licensing agreement with Vir Biotechnology, under which Norgine will commercialise …

pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!

brexit-hintergrund_web

UK life sciences industry does not want no-deal Brexit, says ABPI Chief

Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …

The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026